First Hodgkin Cell Line L428 and the CD30 Antigen
Authors:
- 25 November 2013
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 28 (1) , 1-11
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Assignment of the human CD30 (Ki-1) gene to 1p36Genomics, 1992
- In vivo targeting of Hodgkin and Reed‐Sternberg cells of Hodgkin's disease with monoclonal antibody Ber‐H2 (CD30): immimohistological evidenceBritish Journal of Haematology, 1992
- Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's diseaseCell, 1992
- Serum levels of soluble CD30 molecule (Ki-1 antigen) in Hodgkin's disease: relationship with disease activity and clinical stageBritish Journal of Haematology, 1990
- Ki‐1 (CD30) antigen is released by Ki‐1‐positive tumor cells in vitro and in vivo. I. Partial characterization of soluble Ki‐1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme‐linked immunosorbent assayEuropean Journal of Immunology, 1989
- Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferationInternational Journal of Cancer, 1983
- Identification of Hodgkin and sternberg‐reed cells as a unique cell type derived from a newly‐detected small‐cell populationInternational Journal of Cancer, 1982
- Production of a monoclonal antibody specific for Hodgkin and Sternberg–Reed cells of Hodgkin's disease and a subset of normal lymphoid cellsNature, 1982
- Contamination of Hodgkin's disease cell culturesNature, 1981
- Characteristic chromosomal abnormalities in biopsies and lymphoid‐cell lines from patients with burkitt and non‐burkitt lymphomasInternational Journal of Cancer, 1976